Prognostic Values of Platelet-Associated Indicators in Resectable Lung Cancers

Overview

Journal Technol Cancer Res Treat

Specialties Biomedical Engineering
Oncology
Pharmacology

Date 2019 Mar 16

PMID 30871415

Citations 12

Authors

Jing-Jing Wang

Yin-Ling Wang

Xin-Xin Ge

Meng-Dan Xu

Kai Chen

Meng-Yao Wu

Fei-Ran Gong

Min Tao

Wen-Jie Wang

Liu-Mei Shou

Wei Li

Affiliations

Soon will be listed here.

Abstract

Background: Lung cancer is the leading cause of cancer death. Platelet-related indictors, including platelet count, plateletcrit, mean platelet volume, and platelet distribution width, not only associate with morphology and functions of platelet but also correlate with tumor development and metastasis. In the present study, we investigated the values of platelet-related indictors in the prognosis evaluation of resectable lung cancers.

Methods: In total, 101 patients with resectable lung cancer were recruited in this study. Patients were divided into 2 groups according to the median pretreatment values. To evaluate the individual value changes after treatment, we introduced the concept of post-/pretreatment ratio (≤1 indicated value was not increased after treatment, while >1 suggested increased value).

Results: The high pretreatment platelet count level was correlated with larger tumor size. High pretreatment plateletcrit level was associated with more lymph nodes metastasis. Patients with high pretreatment plateletcrit level had worse overall survival, whereas pretreatment platelet count, mean platelet volume, and platelet distribution width levels were not correlated with outcomes. Surgery had no impact on the values of platelet count, plateletcrit, mean platelet volume, or platelet distribution width. Adjuvant chemotherapy significantly decreased the values of platelet count and plateletcrit, whereas it had no effect on the values of mean platelet volume or platelet distribution width. Whole course of treatment (surgery combined with adjuvant chemotherapy) significantly decreased the values of platelet count and platelet distribution width, whereas it had no effect on the values of plateletcrit or mean platelet volume. Post-/pretreatment platelet count, plateletcrit, mean platelet volume, and platelet distribution width ratios were not correlated with outcomes. Univariate analyses demonstrated that American Joint Committee on Cancer stage and pretreatment plateletcrit level were significant risk factors for prognosis. Cox regression analysis revealed that no factor independently associated with worse survival.

Conclusion: Pretreatment plateletcrit level could be a potential prognostic factor in resectable lung cancers.

Citing Articles

Preoperative platelet distribution width predicts bone metastasis in patients with breast cancer.

Song M, Zhao L, Huang W, Cui M, Liu Y, Wang R BMC Cancer. 2024; 24(1):1066.

PMID: 39210343 PMC: 11360324. DOI: 10.1186/s12885-024-12837-y.

Relation of Mean Platelet Volume (MPV) with Cancer: A Systematic Review with a Focus on Disease Outcome on Twelve Types of Cancer.

Detopoulou P, Panoutsopoulos G, Mantoglou M, Michailidis P, Pantazi I, Papadopoulos S Curr Oncol. 2023; 30(3):3391-3420.

PMID: 36975471 PMC: 10047416. DOI: 10.3390/curroncol30030258.

Use of Platelet Parameters in the Differential Diagnosis of Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Tuberculous Pleural Effusion.

Ai L, Li J, Ye T, Wang W, Li Y Dis Markers. 2022; 2022:5653033.

PMID: 35531478 PMC: 9068346. DOI: 10.1155/2022/5653033.

Systemic inflammation with sarcopenia predicts survival in patients with gastric cancer.

Liu Y, Ruan G, Ge Y, Li Q, Zhang Q, Zhang X J Cancer Res Clin Oncol. 2022; 149(3):1249-1259.

PMID: 35435489 DOI: 10.1007/s00432-022-03925-2.

Prognostic significance of mean platelet volume in patients with lung cancer: a meta-analysis.

Kharel S, Shrestha S, Shakya P, Rawat R, Shilpakar R J Int Med Res. 2022; 50(3):3000605221084874.

PMID: 35313756 PMC: 8943633. DOI: 10.1177/03000605221084874.

References

Kourelis T, Wysokinska E, Wang Y, Yang P, Mansfield A, Tafur A . Early venous thromboembolic events are associated with worse prognosis in patients with lung cancer. Lung Cancer. 2014; 86(3):358-62. PMC: 5046820. DOI: 10.1016/j.lungcan.2014.10.003. View

Ifran A, Hasimi A, Kaptan K, Nevruz O, Beyan C, Erbil K . Evaluation of platelet parameters in healthy apheresis donors using the ADVIA 120. Transfus Apher Sci. 2005; 33(2):87-90. DOI: 10.1016/j.transci.2005.04.007. View

Kurtoglu E, Kokcu A, Celik H, Sari S, Tosun M . Platelet Indices May be Useful in Discrimination of Benign and Malign Endometrial Lesions, and Early and Advanced Stage Endometrial Cancer. Asian Pac J Cancer Prev. 2015; 16(13):5397-400. DOI: 10.7314/apjcp.2015.16.13.5397. View

Verheul H, Hoekman K, Lupu F, Broxterman H, van der Valk P, Kakkar A . Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas. Clin Cancer Res. 2000; 6(1):166-71. View

Kurt M, Onal I, Sayilir A, Beyazit Y, Oztas E, Kekilli M . The role of mean platelet volume in the diagnosis of hepatocellular carcinoma in patients with chronic liver disease. Hepatogastroenterology. 2012; 59(117):1580-2. DOI: 10.5754/hge10444. View

Alexandrakis M, Passam F, Moschandrea I, Christophoridou A, Pappa C, Coulocheri S . Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis. Am J Clin Oncol. 2003; 26(2):135-40. DOI: 10.1097/00000421-200304000-00007. View

Bambace N, Holmes C . The platelet contribution to cancer progression. J Thromb Haemost. 2010; 9(2):237-49. DOI: 10.1111/j.1538-7836.2010.04131.x. View

Tuncel T, Ozgun A, Emirzeoglu L, Celik S, Bilgi O, Karagoz B . Mean platelet volume as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab-combined chemotherapy. Asian Pac J Cancer Prev. 2014; 15(15):6421-3. DOI: 10.7314/apjcp.2014.15.15.6421. View

Hirahara N, Matsubara T, Kawahara D, Mizota Y, Ishibashi S, Tajima Y . Prognostic value of hematological parameters in patients undergoing esophagectomy for esophageal squamous cell carcinoma. Int J Clin Oncol. 2016; 21(5):909-919. PMC: 5055579. DOI: 10.1007/s10147-016-0986-9. View

10.

Ozaksit G, Tokmak A, Kalkan H, Yesilyurt H . Value of the platelet to lymphocyte ratio in the diagnosis of ovarian neoplasms in adolescents. Asian Pac J Cancer Prev. 2015; 16(5):2037-41. DOI: 10.7314/apjcp.2015.16.5.2037. View

11.

Bath P, Algert C, Chapman N, Neal B . Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke. 2004; 35(3):622-6. DOI: 10.1161/01.STR.0000116105.26237.EC. View

12.

Inagaki N, Kibata K, Tamaki T, Shimizu T, Nomura S . Prognostic impact of the mean platelet volume/platelet count ratio in terms of survival in advanced non-small cell lung cancer. Lung Cancer. 2013; 83(1):97-101. DOI: 10.1016/j.lungcan.2013.08.020. View

13.

Ma X, Wang Y, Sheng H, Tian W, Qi Z, Teng F . Prognostic significance of thrombocytosis, platelet parameters and aggregation rates in epithelial ovarian cancer. J Obstet Gynaecol Res. 2013; 40(1):178-83. DOI: 10.1111/jog.12151. View

14.

Kisacik B, Tufan A, Kalyoncu U, Karadag O, Akdogan A, Ozturk M . Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine. 2008; 75(3):291-4. DOI: 10.1016/j.jbspin.2007.06.016. View

15.

Kilincalp S, Coban S, Akinci H, Hamamci M, Karaahmet F, Coskun Y . Neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and mean platelet volume as potential biomarkers for early detection and monitoring of colorectal adenocarcinoma. Eur J Cancer Prev. 2014; 24(4):328-33. DOI: 10.1097/CEJ.0000000000000092. View

16.

Zheng Y, Bueno R . Commercially available prognostic molecular models in early-stage lung cancer: a review of the Pervenio Lung RS and Myriad myPlan Lung Cancer tests. Expert Rev Mol Diagn. 2015; 15(5):589-96. DOI: 10.1586/14737159.2015.1028371. View

17.

Khandekar M, Khurana A, Deshmukh S, Kakrani A, Katdare A, Inamdar A . Platelet volume indices in patients with coronary artery disease and acute myocardial infarction: an Indian scenario. J Clin Pathol. 2006; 59(2):146-9. PMC: 1860313. DOI: 10.1136/jcp.2004.025387. View

18.

Greisenegger S, Endler G, Hsieh K, Tentschert S, Mannhalter C, Lalouschek W . Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events?. Stroke. 2004; 35(7):1688-91. DOI: 10.1161/01.STR.0000130512.81212.a2. View

19.

Sorensen H, Mellemkjaer L, Olsen J, Baron J . Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000; 343(25):1846-50. DOI: 10.1056/NEJM200012213432504. View

20.

Osada J, Rusak M, Kamocki Z, Dabrowska M, Kedra B . Platelet activation in patients with advanced gastric cancer. Neoplasma. 2010; 57(2):145-50. DOI: 10.4149/neo_2010_02_145. View